New data indicates various doses of roflumilast reduced allergen-induced airway inflammation in asthma patients.
The effective use of clinical asthma features helped researchers diagnose asthma-COPD overlap syndrome in a group of COPD patients in a recent study.
Researchers have discovered new insight into the causes of asthma by identifying three distinct groups of asthma patients characterised by the activity of different genes in the airways.
A recent Australian study highlights the need for a new generation of effective inhalable medications for patients with asthma and other lung diseases.
A recent review examined the role of psychological factors related to the unsuccessful fulfillment of optimal levels of asthma control.
Eucapnic voluntary hyperventilation (EVH) could not be used interchangeably with treadmill running to diagnose exercise-induced bronchoconstriction in children with asthma.
Inhaled tiotropium shown to be a safe and effective therapy for adolescents with asthma in a new study.
Cipla will soon launch Synchrobreathe, an inhaler intended to aid in the management of obstructive airway disease.
In people with asthma, the cells that line the airways in the lungs are unusually shaped and “scramble around like there’s a fire drill going on.”
Synairgen has announced that AstraZeneca has initiated its Phase IIa clinical trial of the drug AZD9412.
The program will bring European doctors to work together with local healthcare professionals in Zambia, which ranks number one in the world for asthma mortality.
According to new research, hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy.
AstraZeneca has partnered with the New Zealand-based company Adherium Limited to create a smart inhaler adherence program for patients.
Children with asthma who are exposed to secondhand smoke are more likely to be obese, according to Mayo Clinic researchers.
According to health experts, childhood asthma rates have decreased by a third over the past decade.
Propeller Health has received US FDA 510(k) clearance to market its Propeller platform in association with medications using GlaxoSmithKline’s Diskus dry powder inhaler.
AstraZeneca and Kyowa Hakko Kirin have entered into an agreement for an exclusive option to commercialize the antibody benralizumab for the treatment of asthma and COPD in Japan.
Emissions of sulfur dioxide has decreased over the past 30 years but the pollutant is still dangerous for asthmatics, according to researchers.
Researchers report that lipid levels in the blood of children are associated with respiratory conditions like asthma and allergies.
According to Boston Children’s Hospital, new research supports targeting sensory nerve endings in the lungs with a selective drug as a new method for controlling asthma.